313696-91-2

Upstream product

• 313696-89-8 (5S,6S,7R)-(E)-1-(tert-butyldiphenylsilyloxy)-6-hydroxy-8-(para-methoxybenzyloxy)-5,7-dimethyl-3-octene 
• 313696-88-7 (5S,6S,7R)-(E)-1-(tert-butyldiphenylsilyloxy)-6,8-(para-methoxybenzylidene)dioxy-5,7-dimethyl-3-octene 
• 313696-86-5 (5S,6S,7R)-(E)-8-benzyloxy-1-(tert-butyldiphenylsilyloxy)-6-hydroxy-5,7-dimethyl-3-octene 
• 313696-87-6 (5S,6S,7R)-(E)-1-(tert-butyldiphenylsilyloxy)-6,8-dihydroxy-5,7-dimethyl-3-octene 
• 123-11-5 4-methoxy-benzaldehyde 
• 4009-98-7 (methoxymethyl)triphenylphosphonium chloride 
• 313696-90-1 (2S,3S,4S)-(E)-8-(tert-butyldiphenylsilyloxy)-3-(para-methoxybenzyloxy)-2,4-dimethyl-5-octen-1-al 

Downstream Products

• 262279-34-5 (3R,4R,5R,9S,10S,12S,13R,14S)-12-(tert-butyldimethylsilyloxy)-10,14-dimethoxy-4-(para-methoxybenzyloxy)-3,5,9,13-tetramethyl-6,16-dioxo-1-hexadecanal 2,2-dimethyl-1,3-propanediol acetal 
• 262279-37-8 C₆₆H₈₉N₃O₁₅Si 
• 262279-42-5 9-{2''-[14-acetoxy-16-(5,5-dimethyl-[1,3]dioxan-2-yl)-6-hydroxy-4,8-dimethoxy-5,9,13,15-tetramethyl-12-oxo-hexadec-1-enyl]-[2,4';2',4'']teroxazol-4-yl}-3-(tert-butyl-diphenyl-silanyloxy)-9-methoxy-8-methyl-7-oxo-non-5-enoic acid 
• 262279-36-7 C₇₂H₁₀₅N₃O₁₆Si₂ 
• 313696-74-1 (3R,4R,5R)-(E)-4-(para-methoxybenzyloxy)-3,5-dimethyl-6-oxo-1-ol 2,2-dimethyl-1,3-propane acetal 
• 313696-72-9 (3R,4R,5R,9S,12S,13R,14S)-(E)-12-(tert-butyldimethylsilyloxy)-6-hydroxy-10,14-dimethoxy-4-(para-methoxybenzyloxy)-3,5,9,13-tetramethyl-16-trimethylacetyloxy-hexadec-7-en-1-al 2,2-dimethyl-1,3-propanediol acetal 
• 262279-38-9 C₆₃H₈₂N₄O₁₄Si 
• 313696-92-3 (3R,4R,5S)-(E)-9-(tert-butyldiphenylsilyloxy)-4-(para-methoxybenzyloxy)-3,5-dimethyl-6-nonen-1-al 2,2-dimethyl-1,3-propane acetal 

Relevant academic research and scientific papers

Total synthesis of the actin-depolymerizing agent (-)-mycalolide A: Application of chiral silane-based bond construction methodology

A highly convergent asymmetric synthesis of the actin-depolymerizing agent (-)-mycalolide A has been achieved through the assembly and union of the C1-C19 trisoxazole fragment 2 and the C20-C35 aliphatic fragment 3, respectively. The C1-C19 fragment 2 was